Journal of Natural Remedies

Open Access Open Access  Restricted Access Subscription Access

Evaluating Role of Cholagogue and Choleretic Drugs in the Management of NIDDM Related to Post Cholecystectomy-A Pilot Clinical Trial


Affiliations
1 Department of Kayachikitsa, C. B. P. A. C. S, Khera Dabar, Delhi - 110073, New Delhi, India
2 Department of Panchakarma, C. B. P. A. C. S, Delhi - 110073, New Delhi, India
3 Ch. Brahm Prakash Ayurveda Charaka Samsthana, Delhi - 110073, New Delhi, India
 

Diabetes becomes a global health burden, affecting almost one third of world population. This figure is self explanatory for its alarming growth and concern to be given for its prevention and management. It is erroneous to treat it as a disease rather it should be treated as a syndrome, because rarely it is presented in its discrete form i.e. only hyperglycemia as a clinical feature. Being a metabolic disease it is almost always accompanied with many other diseases like hypothyroidism, hypertension, fatty liver disease, obesity, dyslipidemia, etc. According to the known pathophysiology of diabetes, hyperglycemia is said to be responsible for dyslipidemia, constant high sugar level in blood produces dreaded effect at micro as well as macro- vascular level. This established pathology of the disease revolves around high glucose level in blood and make it the diagnostic parameter for diabetes. Although the cause of hyperglycemia are also well defined but there is one missing link which is totally neglected by the modern science i.e., role of liver in the pathogenesis of diabetes. Do any way hampered liver functions affect insulin production or its utilization by the cell- the question that required answer. This clinical trial is based on materializing the concept that effective bile secretion improves insulin activity. This is a pilot study carried out on 15 known patient of non insulin dependent diabetes. The study showed that 66.6% patient has diabetes associated with hypothyroidism followed by dyslipidemia (60%). The study drug shows significant (p< 0.001) reduction in both FBS and PPBS and improve the presenting symptoms effectively.

Keywords

Bile, Dyslipidemia, Hyperglycemia, Insulin.
Font Size

User

Notifications
JOURNAL COVERS
  

  • Barbeau WE, Bassaganya-Riera J, Hontecillas R. Putting the pieces of the puzzle together - A series of hypotheses on the etiology and pathogenesis of type 1 diabetes. 2006; 68:607–9.

  • Ogura Y, Ito T, Ogura M. Effect of diabetes and of 7 alphahydroxycholesterol infusion on the profile of bile acids secreted by the isolated rat livers. Biol Chem Hoppe Seyler. 1986; 367:1095–99. https://doi.org/10.1515/ bchm3.1986.367.2.1095 PMid:3539141

  • Peng H, Hagopian W. Environmental factors in the development of Type 1 diabetes. Rev Endocr Metab Disord; 2007. https://doi.org/10.1007/s11154-006-9024-y PMid:17203405

  • Rozanova GN, Voevodin DA, Stenina MA, Kushnareva MV.Pathogenetic role of dysbacteriosis in the development of complications of type 1 diabetes mellitus in children.Bull Exp Biol Med. 2002; 133:164–6. https://doi.org/10.1023/A:1015503006854 PMid:12428285

  • Slivka OI, Zelinskii BA, Zelinskii ST. Bile acids in the bile in diabetes mellitus. Probl Endokrinol (Mosk). 1979; 25:16– 9.

  • Thomson AB. Uptake of bile acids into rat intestine. Effect of diabetes mellitus. Diabetes. 1983; 32:900–7. https://doi.org/10.2337/diabetes.32.10.900 PMid:6618019

  • Al-Salami H, Butt G, Tucker I, Mikov M. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Pharmacol Rep.2008; 60:532–41. PMid:18799822

  • Al-Salami H, Butt G, Tucker I, Fawcett PJ, Golocorbin-Kon S, Mikov I, Mikov M. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats. European Journal of Drug Metabolism and Pharmacokinetics. 2009; 34:43– 50. https://doi.org/10.1007/BF03191383 PMid:19462928

  • Mikov M, Fawcett JP, Kuhajda K, Kevresan S. Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents. 2006; 31:237–51.

  • Kuhajda K, Kandrac J, Kevresan S, Mikov M, Fawcett JP.Structure and origin of bile acids: An overview. European Journal of Drug Metabolism and Pharmacokinetics.2006a; 31:135–43. https://doi.org/10.1007/BF03190710 PMid:17136858

  • Gaur C, Mathur A, Agarwal A, Verma K, Jain R, Swaroop A. Diabetic autonomic neuropathy causing gall bladder dysfunction. J Assoc Physicians India. 2000 Jun; 48(6):603–5. PMid:11273539

  • Kulakowski EC, Maturo J. Hypoglycemic properties of Taurine - Not mediated by enhanced insulin release.Biochemical Pharmacology. 1984; 33:2835–38 https://doi.org/10.1016/0006-2952(84)90204-1

  • Bennion LJ, Grundy SM. Effects of diabetes mellitus on cholesterol metabolism in man. 1977; 296:1365–71.

  • Meinders AE, Vanbergehenegouwen GP, Willekens FLA, Schwerzel AL, Ruben A, Huybregts AWM. Biliary lipid and bile-acid composition in insulin- dependent diabetesmellitus - arguments for increased intestinal bacterial bile- acid degradation. Digestive Diseases and Sciences.1981c; 26:402–8. https://doi.org/10.1007/BF01313581 PMid:7018861

  • Kajaria D. Chandola HM. Dislipidemia cause or consequence of diabetes- reanalyzing the pathogenesis with the vision of Ayurveda. Research & Reviews: Journal of Herbal Science. Volume 3, Issue 2, 30-34.

  • Sharma H, Chandola HM. Prameha in ayurveda: Correlation with obesity, metabolic syndrome, and diabetes mellitus.part 1-etiology, classification, and pathogenesis.The Journal of Alternative and Complementary Medicine.2011; 17(6):491–6. https://doi.org/10.1089/acm.2010.0396 PMid:21649515

  • Tripathi SN, Chandola HM. Study on variations in diabetes mellitus (Prameha) with special reference to plasma insulin, cortisol and catecholamines. Bajaj JS, editor.Diabetes mellitus in Developing Countries. New Delhi, India: Interprint; 1984. p. 125–8.

  • Shukla B, Visen PK, Patnaik GK, Dhawan BN. Choleretic effect of picroliv, the hepatoprotective principle of Picrorhiza kurroa. Planta Med. 1991 Feb; 57(1):29–33.https://doi.org/10.1055/s-2006-960010 PMid:2062954

  • Husain GM, Singh PN, Kumar V. Antidiabetic activity of standardized extract of Picrorhiza kurroa in rat model of NIDDM. Drug Discov Ther. 2009 Jun; 3(3):88–92.PMid:22495535

  • Singh H. Hepatoprotective effect of Bhumyamalki (Phyllanthus fraternus Webster) and Phaltrikadi decoction in patients of acute viral hepatitis. Indian Journal of Traditional Knowledge. 2008; 7(4):560–5.

  • Paithankar VV, Raut KS, Charde RM, Vyas JV. Phyllanthus Niruri: A magic Herb. Research in Pharmacy. 2011; 1(4):1–9.

  • Okoli CO, Obidike IC, Ezike AC, Akah PA, Salawu OA.Studies on the possible mechanisms of antidiabetic activity of extract of aerial parts of Phyllanthus niruri. Pharm Biol.2011 Mar; 49(3):248–55. https://doi.org/10.3109/1388020 9.2010.501456 PMid:21323477

  • Prabu K, Kanchana N, Mohamed SA. Hepatoprotective effect of Eclipta alba on Paracetamol induced liver toxicity in rats. J Microbiol Biotech Res. 2011; 1(3):75–9.

  • Ananthi J, Prakasam A, Pugalendi KV. Antihyperglycemic activity of Eclipta alba leaf on alloxan-induced diabetic rats. Yale J Biol Med. 2003; 76(3):97–102. PMid:15369623 PMCid:PMC2582707

  • Darbar S, Bose A, Bhaumik KU, Roy B, Chatterjee N, Pal KT. Antioxidant and hepatoprotective effect of andrographis paniculata leaf extract on diclofenac induced hepatotoxicity in rats. Pharmacologyonline. 2009; 2:95– 108.

  • Shukla B, Visen PK, Patnaik GK, Dhawan BN.Choleretic effect of andrographolide in rats and guinea pigs. Planta Med. 1992 Apr; 58(2):146–9. https://doi.org/10.1055/s-2006-961416 PMid:1529026

  • Singh H, Sharma YK. Clinical evaluation of the hepatoprotective effect of Katuki (Picrorhiza kurroa Royle ex Benth.) processed in Guduchi (Tinospora cordifolia Wild.) Miers in patients receiving lipid lowering drugs (Statins). Indian J Traditional Knowledge. 2011; 10(4):657–60.

  • Singh T, Sinha N, Singh. Biochemical and histopathological effects on liver due to acute oral toxicity of aqueous leaf extract of Ecliptaalba on female Swiss albino mice.Indian J Pharmacol. 2013 Jan-Feb; 45(1):61–5. https:// doi.org/10.4103/0253-7613.106437 PMid:23543876 PMCid:PMC3608297

  • Manjrekar AP, Jisha V, Bag PP, Adhikary B, Pai MM, Hegde A, Nandini M. Effect of Phyllanthus niruri Linn treatment on liver, kidney and testes in CCl4 induced hepatotoxic rats. Indian Journal of Experimental Biology. 2008; 46:514–20. PMid:18807755

  • Sandborn WJ, Targan SR, Byers VS, Rutty DA, Mu H, Zhang X, Tang T. Andrographis paniculata Extract (HMPL004) for Active Ulcerative Colitis. Am J Gastroenterol.2013; 108:90–8. https://doi.org/10.1038/ajg.2012.340 PMid:23044768 PMCid:PMC3538174


Abstract Views: 345

PDF Views: 168




  • Evaluating Role of Cholagogue and Choleretic Drugs in the Management of NIDDM Related to Post Cholecystectomy-A Pilot Clinical Trial

Abstract Views: 345  |  PDF Views: 168

Authors

Divya Kajaria
Department of Kayachikitsa, C. B. P. A. C. S, Khera Dabar, Delhi - 110073, New Delhi, India
Arun Gupta
Department of Panchakarma, C. B. P. A. C. S, Delhi - 110073, New Delhi, India
H. M. Chandola
Ch. Brahm Prakash Ayurveda Charaka Samsthana, Delhi - 110073, New Delhi, India

Abstract


Diabetes becomes a global health burden, affecting almost one third of world population. This figure is self explanatory for its alarming growth and concern to be given for its prevention and management. It is erroneous to treat it as a disease rather it should be treated as a syndrome, because rarely it is presented in its discrete form i.e. only hyperglycemia as a clinical feature. Being a metabolic disease it is almost always accompanied with many other diseases like hypothyroidism, hypertension, fatty liver disease, obesity, dyslipidemia, etc. According to the known pathophysiology of diabetes, hyperglycemia is said to be responsible for dyslipidemia, constant high sugar level in blood produces dreaded effect at micro as well as macro- vascular level. This established pathology of the disease revolves around high glucose level in blood and make it the diagnostic parameter for diabetes. Although the cause of hyperglycemia are also well defined but there is one missing link which is totally neglected by the modern science i.e., role of liver in the pathogenesis of diabetes. Do any way hampered liver functions affect insulin production or its utilization by the cell- the question that required answer. This clinical trial is based on materializing the concept that effective bile secretion improves insulin activity. This is a pilot study carried out on 15 known patient of non insulin dependent diabetes. The study showed that 66.6% patient has diabetes associated with hypothyroidism followed by dyslipidemia (60%). The study drug shows significant (p< 0.001) reduction in both FBS and PPBS and improve the presenting symptoms effectively.

Keywords


Bile, Dyslipidemia, Hyperglycemia, Insulin.

References





DOI: https://doi.org/10.18311/jnr%2F0%2F15797